UY34120A - Combinación sinérgica para el tratamiento de diabetes mellitus tipo 2 - Google Patents

Combinación sinérgica para el tratamiento de diabetes mellitus tipo 2

Info

Publication number
UY34120A
UY34120A UY0001034120A UY34120A UY34120A UY 34120 A UY34120 A UY 34120A UY 0001034120 A UY0001034120 A UY 0001034120A UY 34120 A UY34120 A UY 34120A UY 34120 A UY34120 A UY 34120A
Authority
UY
Uruguay
Prior art keywords
treatment
diabetes type
mellitus diabetes
synergic combination
synergic
Prior art date
Application number
UY0001034120A
Other languages
English (en)
Inventor
Radwan Farouk
Original Assignee
Pri S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pri S A filed Critical Pri S A
Publication of UY34120A publication Critical patent/UY34120A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La invención se refiere a una combinación sinérgica de cromo trivalente, biotina y ginseng americano eficaz para el tratamiento de diabetes mellitus tipo 2. También se refiere a composiciones dietéticas que incluyen dicha combinación que resultan apropiadas para el tratamiento de diabetes mellitus tipo 2 en pacientes obesos. También se refiere a la utilización de dicha combinación para la preparación de un medicamento para el tratamiento de dicha diabetes
UY0001034120A 2011-06-08 2012-06-07 Combinación sinérgica para el tratamiento de diabetes mellitus tipo 2 UY34120A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201130956A ES2395529B1 (es) 2011-06-08 2011-06-08 Combinación sinérgica para el tratamiento de la diabetes mellitus tipo 2.

Publications (1)

Publication Number Publication Date
UY34120A true UY34120A (es) 2013-01-03

Family

ID=46513800

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001034120A UY34120A (es) 2011-06-08 2012-06-07 Combinación sinérgica para el tratamiento de diabetes mellitus tipo 2

Country Status (9)

Country Link
US (1) US20140106006A1 (es)
EP (1) EP2717872B1 (es)
AR (1) AR086862A1 (es)
BR (1) BR112013031487B1 (es)
ES (2) ES2395529B1 (es)
MX (1) MX354283B (es)
PT (1) PT2717872T (es)
UY (1) UY34120A (es)
WO (1) WO2012168854A1 (es)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2489235A (en) 1947-07-24 1949-11-22 Hoffmann La Roche Synthesis of biotin
EP1001793B1 (en) 1997-08-08 2005-09-14 Nutrition 21 Chromium/biotin treatment of type ii diabetes
IT1311495B1 (it) 1999-06-09 2002-03-13 Mendes S U R L Composizione comprendente sfingomielinasi alcalina, utilizzabile qualeprodotto dietetico, integratore alimentare o medicamento.
EP1305018A4 (en) * 2000-08-02 2006-08-30 Pharmanutrients METHODS AND COMPOUNDS FOR PROPHYLAXIS AND / OR TREATMENT OF DIABETES AND GLUCOSE DEREGULATION
US6365176B1 (en) 2000-08-08 2002-04-02 Functional Foods, Inc. Nutritional supplement for patients with type 2 diabetes mellitus for lipodystrophy
CA2438063A1 (en) * 2001-02-27 2002-09-06 Nutrition 21, Inc. Chromium/biotin treatment of dyslipidemia and diet-induced post prandial hyperglycemia
CN1273152C (zh) 2001-05-11 2006-09-06 上海展望集团有限公司 一种治疗糖尿病的胶囊及其生产方法
DE602006009641D1 (de) 2005-04-07 2009-11-19 Astrum Therapeutics Pty Ltd Komplementäre zusammensetzungen zur verringerung der blutzuckerspiegel und zur behandlung von diabetes
EP1996176B1 (en) 2006-02-21 2010-05-19 Astrum Therapeutics Pty, Ltd. Compositions to reduce blood glucose levels and treat diabetes
US20080102137A1 (en) * 2006-10-31 2008-05-01 Guffey Manning V R Composition and method for etiological treatment and prevention of diseases and/or complications associated with chronic glucose metabolism destabilization
CN101390902A (zh) * 2008-10-10 2009-03-25 北京冠五洲生物科学研究院 用于优生优育预防出生缺陷与改善记忆的药物组合物

Also Published As

Publication number Publication date
BR112013031487A2 (pt) 2016-12-13
MX2013014276A (es) 2014-05-28
ES2395529A1 (es) 2013-02-13
ES2395529B1 (es) 2014-04-11
US20140106006A1 (en) 2014-04-17
EP2717872B1 (en) 2016-04-06
WO2012168854A1 (en) 2012-12-13
EP2717872A1 (en) 2014-04-16
MX354283B (es) 2018-02-21
BR112013031487B1 (pt) 2020-03-03
PT2717872T (pt) 2016-07-11
ES2579829T3 (es) 2016-08-17
AR086862A1 (es) 2014-01-29

Similar Documents

Publication Publication Date Title
LTPA2020510I1 (lt) Pakeistieji 4-fenil-piridinai, skirti su NK-receptoriumi susijusių ligų gydymui
CO7020879A2 (es) Miméticos de apelina sintéticos para el tratamiento de insuficiencia cardíaca
CL2015000177A1 (es) Composición para el tratamiento de la hiperlipidemia que comprende un derivado de oxintomodulina
UY33353A (es) Compuestos adecuados para el tratamiento de trastornos metabolicos y metodos de preparacion
CO6821964A2 (es) Compuestos para el tratamiento de la adicción
CR20150078A (es) Análogos de piridazina 1,4-disustituida y métodos para el tratamiento de condiciones relacionadas con la deficiencia de smn
CO6940432A2 (es) Compuestos de 1-arilcarbonilo-4-oxi-piperidina útiles para el tratamiento de enfermedades neurodegenerativas
CO7061081A2 (es) Derivados macrocíclicos para el tratamiento de enfermedades
CR20210079A (es) Sulfamoilarilamidas y su uso como medicamentos para el tratamiento de la hepatitis b
CO7030960A2 (es) Inhibidores de pak para el tratamiento de los trastornos de proliferación celular
CO6990725A2 (es) Composiciones blanqueadoras para el cuidado oral
CL2014001993A1 (es) Uso de melatonina para el tratamiento de trastornos del ritmo circadiano
UY33910A (es) 6-cicloalquil-pirazolopirimidinonas para el tratamiento de trastornos del SNC
CO6801718A2 (es) Composición terapéutica para el tratamiento de glioblastoma
UY34158A (es) Composicion herbicida
CO6821965A2 (es) 1-piperazino-3-fenil-indanos deuterados para el tratamiento de esquizofrenia
HK1215794A1 (zh) 用於治療疾病的同種異體自噬體富集組合物
IL232194A (en) An iontophoresis cross-linking preparation for use in keratoconus treatment
IT1406864B1 (it) Composizione per il trattamento dell'acne
IL231126A0 (en) Use of an organic compound to treat Noonan syndrome
UY34001A (es) Agentes para el control de la avispa de las agallas
BR112013015048A2 (pt) composição para o tratamento de distúrbios metabólicos
ITRM20120405A1 (it) Compounds for use in the treatment of disorders that are ameliorated by inhibition of hdac
BR112014011898A2 (pt) métodos e composições para o tratamento de diabetes e sintomas relacionados
BR112013030930A2 (pt) composições farmacêuticas combinadas para o tratamento de tumores

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20201020